Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Medical genetics

Building Your Care Team and Ensuring Safety

At a Glance

People with severe MTHFR deficiency need coordinated care led by a metabolic geneticist. They should carry an emergency letter, avoid nitrous oxide completely, and make an individualized plan for medications, fasting, hydration, anesthesia, and blood-clot prevention before surgery.

Managing a rare condition like severe MTHFR deficiency requires more than just one doctor; it takes a coordinated “medical home” of specialists who communicate with each other [1]. Because this condition affects the brain, blood vessels, and metabolic pathways, you will need a team that understands how high homocysteine impacts different parts of the body [2][3].

Your Core Medical Team

Your care is typically anchored by a Metabolic Geneticist—a specialist in inherited metabolic diseases who will manage your treatment regimen (betaine, folate, and B12) [1]. However, several other specialists play vital roles:

  • Neurologist: Since high homocysteine can cause seizures, movement issues (ataxia), or developmental delays, a neurologist monitors brain health and manages any necessary anti-seizure medications [3][4].
  • Hematologist / Vascular Specialist: Because severe MTHFR deficiency significantly increases the risk of blood clots (thrombosis), a hematologist may help manage your risk, especially if you have a history of thrombosis or before surgeries [1][5].
  • Ophthalmologist: If you have documented or suspected visual findings, an ophthalmologist may be required, as some late-onset patients experience vision problems [4][2].
  • Metabolic Dietitian: They help ensure you or your child are getting the right balance of nutrients, particularly if methionine supplementation is required [6].

Critical Safety: The Nitrous Oxide Warning

One of the most important things you must share with any medical provider is that nitrous oxide (laughing gas, N2O, or Entonox) is strictly contraindicated [7][8]. Nitrous oxide is commonly used in dental offices and for minor surgeries, but for someone with severe MTHFR deficiency, it can be extremely dangerous.

  • The Biological Clash: Nitrous oxide inactivates Vitamin B12 in the body. Since the MTHFR pathway already has a broken link, and B12 is needed for the “backup” recycling pathway, using nitrous oxide can precipitate serious metabolic and neurological deterioration [7][9].
  • The Risk: This sudden metabolic “crash” can lead to severe neurological deterioration, including confusion, hallucinations, seizures, or a condition called subacute combined degeneration of the spinal cord [10][11][12].
  • Anesthesia Planning: Modern anesthetics like propofol or sevoflurane are options, but the anesthesia team and metabolic specialist must choose an individualized plan [7][8].

Surgery and Anesthesia Precautions

Any surgery, no matter how minor, requires advanced planning with your metabolic team. High homocysteine makes the blood “sticky,” and surgery increases the risk of dangerous blood clots [1][13]. Ensure you have an individualized written perioperative plan covering:

  1. Thrombosis Prevention: Depending on the procedure and bleeding risk, your team may order blood thinners (like heparin) before and after surgery. Do not start anticoagulants yourself. They may also use mechanical tools like compression stockings or “boots” (SCDs) [7].
  2. Hydration: Being dehydrated makes blood even more likely to clot. Your surgical team should ensure you receive individualized IV fluids during the fasting period [7].
  3. Early Movement: “Ambulation”—or getting out of bed to walk as soon as possible after surgery—is one of the best ways to prevent blood clots in MTHFR patients [7].
  4. Fasting: Instructions on how to administer essential betaine and vitamins when you are not allowed to eat or drink.
  5. The “Emergency Letter”: Always carry a letter from your metabolic geneticist that explains your diagnosis, lists your medications, provides a sick-day protocol, and explicitly warns against nitrous oxide. This letter is your most important tool in an emergency room or a new doctor’s office [6].

Common questions in this guide

Who should be part of a care team for severe MTHFR deficiency?
A metabolic geneticist usually coordinates care and the treatment plan. Depending on symptoms and procedures, the team may also include a neurologist, hematologist or vascular specialist, ophthalmologist, metabolic dietitian, and anesthesiologist.
Why is nitrous oxide unsafe with severe MTHFR deficiency?
Nitrous oxide, also called laughing gas, can inactivate vitamin B12 and disrupt the body's backup pathway for processing homocysteine. In severe MTHFR deficiency, this can trigger serious metabolic and neurological deterioration, including confusion, hallucinations, or seizures, so it should be avoided.
What should be planned before surgery or anesthesia?
The metabolic team and surgical or anesthesia teams should create a written plan before any procedure. It should cover safe administration of betaine and vitamins during fasting, hydration, clot prevention, early movement, and anesthetic choices, with nitrous oxide explicitly excluded. The plan must be individualized for the procedure and bleeding risk.
How can blood clot risk be reduced around surgery?
The care team may use individualized blood-thinner treatment, such as heparin, when appropriate, along with compression stockings or compression boots. Adequate fluids during fasting and walking as soon as safely possible also help reduce clot risk. Never start an anticoagulant without clinician instructions.
What should an emergency letter for MTHFR deficiency contain?
It should state the diagnosis, current medicines, sick-day instructions, and the strict warning to avoid nitrous oxide. Carrying it can help emergency and new medical teams understand the condition and follow the established plan.
Should someone with severe MTHFR deficiency wear medical alert identification?
A medical alert card or bracelet that states severe MTHFR deficiency and no nitrous oxide can quickly alert healthcare workers, especially in an emergency. Keep it with you and make sure your primary care doctor has the current treatment plan.

Get notified when new evidence is published on Homocystinuria due to methylene tetrahydrofolate reductase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency.

    Huemer M, Diodato D, Schwahn B, et al.

    Journal of inherited metabolic disease 2017; (40(1)):21-48 doi:10.1007/s10545-016-9991-4.

    PMID: 27905001
  2. 2

    Phenotype, treatment practice and outcome in the cobalamin-dependent remethylation disorders and MTHFR deficiency: Data from the E-HOD registry.

    Huemer M, Diodato D, Martinelli D, et al.

    Journal of inherited metabolic disease 2019; (42(2)):333-352 doi:10.1002/jimd.12041.

    PMID: 30773687
  3. 3

    Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency.

    Huemer M, Mulder-Bleile R, Burda P, et al.

    Journal of inherited metabolic disease 2016; (39(1)):115-24 doi:10.1007/s10545-015-9860-6.

    PMID: 26025547
  4. 4

    Clinical and molecular characterization of adult patients with late-onset MTHFR deficiency.

    Marelli C, Lavigne C, Stepien KM, et al.

    Journal of inherited metabolic disease 2021; (44(3)):777-786 doi:10.1002/jimd.12323.

    PMID: 33089527
  5. 5

    Manifestations of neurological symptoms and thromboembolism in adults with MTHFR-deficiency.

    Rommer PS, Zschocke J, Fowler B, et al.

    Journal of the neurological sciences 2017; (383()):123-127 doi:10.1016/j.jns.2017.10.035.

    PMID: 29246599
  6. 6

    First Revision of the Guidelines for the Diagnosis and Management of Remethylation Disorders.

    Olivieri G, Bordugo A, Burnyte B, et al.

    Journal of inherited metabolic disease 2026; (49(4)):e70177 doi:10.1002/jimd.70177.

    PMID: 42231716
  7. 7

    Methylenetetrahydrofolate Reductase Deficiency: A Case Report.

    Hale N, Minzola D

    AANA journal 2020; (88(4)):303-306.

    PMID: 32718428
  8. 8

    Methylene Tetrahydrofolate Reductase Deficiency: the Hidden Risk in Paediatric Anaesthesia.

    Orhon ZN, Koltka EN, Tüfekçi S, et al.

    Turkish journal of anaesthesiology and reanimation 2017; (45(5)):277-281 doi:10.5152/TJAR.2017.68366.

    PMID: 29114412
  9. 9

    Right iliac deep vein thrombosis and pulmonary embolism associated with recreational nitrous oxide: a case report.

    Bizouard T, Caplette C, Duval D, et al.

    International journal of emergency medicine 2024; (17(1)):169 doi:10.1186/s12245-024-00689-z.

    PMID: 39497058
  10. 10

    Venous thrombosis after nitrous oxide abuse, a case report.

    Pratt DN, Patterson KC, Quin K

    Journal of thrombosis and thrombolysis 2020; (49(3)):501-503 doi:10.1007/s11239-019-02010-9.

    PMID: 31820264
  11. 11

    A rise in cases of nitrous oxide abuse: neurological complications and biological findings.

    Einsiedler M, Voulleminot P, Demuth S, et al.

    Journal of neurology 2022; (269(2)):577-582 doi:10.1007/s00415-021-10702-7.

    PMID: 34245346
  12. 12

    First episode of catatonia followed by a psychotic episode related to chronic nitrous oxide use: A case report.

    Taillefer de Laportalière T, Redon M, Roussin A, et al.

    Drug and alcohol review 2025; (44(3)):908-912 doi:10.1111/dar.14012.

    PMID: 39901315
  13. 13

    Nitrous oxide abuse leading to extreme homocysteine levels and thrombosis in young adults: a case series.

    Caris MG, Kuipers RS, Kiestra BE, et al.

    Journal of thrombosis and haemostasis : JTH 2023; (21(2)):276-283 doi:10.1016/j.jtha.2022.10.002.

    PMID: 36700505

This page is for informational purposes only and does not constitute medical advice. Your metabolic geneticist and anesthesia team should create an individualized plan for MTHFR deficiency; never change medicines or anticoagulants without their guidance.